Exscientia announces expansion of its current collaboration with sanofi to include existing exscientia programme

Oxford, england--(business wire)--exscientia plc (nasdaq: exai) today announced that sanofi is adding a new discovery stage programme identified and initially advanced by exscientia into the current collaboration. in this programme, exscientia has designed a novel lead series with a potential best in class profile, with preliminary data showing good potency and selectivity towards the target and differentiated molecular properties. “sanofi adding an exscientia discovery stage programme into the.
EXAI Ratings Summary
EXAI Quant Ranking